Skip to main content

Advertisement

Advertisement

World

France approves Johnson & Johnson's Janssen COVID-19 vaccine

France approves Johnson & Johnson's Janssen COVID-19 vaccine

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration//File Photo

PARIS: France's health regulator said on Friday (Mar 12) it had approved Johnson & Johnson's single-dose COVID-19 vaccine for use in France, a day after it was approved by the European Union authorities.

"The COVID-19 Janssen vaccine can be used on people from the age of 18 ... within the framework of the French vaccination strategy, including for people aged 65 and older and who might have illnesses," the Haute Autorite de Sante (HAS) said in a statement.

HAS said the vaccine was efficient and well tolerated by patients. It will be the fourth vaccine on the French market.

The European Medicines agency (EMA) approved the Johnson & Johnson vaccine on Thursday, paving the way for the first shots to be delivered in a month.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Advertisement

Also worth reading

Advertisement